Pharma Medica
Cheryl Ethier has extensive work experience in quality assurance and project management roles within the healthcare and technology industries. Cheryl currently holds the position of Vice President Quality Assurance & Chief Privacy Officer at Pharma Medica Research Inc., where they have been working since 2021. Prior to this, Cheryl was the Director Quality Assurance & Chief Privacy Officer at the same company.
Before joining Pharma Medica Research Inc., Cheryl worked as the Clinical Research Program Director - Quality Assurance Manager at Create Fertility Centre from 2019 to 2021. Cheryl also served as the Quality Improvement Project Manager at Mount Sinai Hospital (Toronto), Sinai Health System from 2017 to 2019.
Earlier in their career, Cheryl served as an Innovation Manager at Microsoft Innovation Center from 2011 to 2015. Cheryl also worked at Mount Sinai Hospital, Toronto as a Critical Care Research Project Manager from 2007 to 2010, and at the University Health Network as a Clinical Research Program Manager from 2003 to 2007.
Cheryl Ethier has a Certified Six Sigma Green Belt from McGill University. Cheryl also has a degree in Project Management and Leadership from the University of Toronto - University College. Cheryl has a Bachelor's degree in Psychology, a Bachelor's degree in Mass Communication/Media Studies, and a Master's degree in Public Policy and Law, all from York University. In addition, they have obtained several certifications including "How to Scale Social Impact" from NovoEd, "Essentials of Nonprofit Strategy," "Global Social Entrepreneurship," and "Organizational Capacity: Assessment to Action" from Philanthropy University, and "Certified Clinical Research Professional" from ACRP Canada. Cheryl has also achieved a Green Belt Six Sigma certification from McGill University.
Pharma Medica
Pharma Medica Research Inc is a full service contract research organization based in the greater Toronto area. We focus primarily on phase I, first-in-man, and bioequivalence trials in healthy volunteers, special populations, and patients. By remaining specialized in this area, we have developed true expertise in the field. Our track record speaks for itself we have completed over 1500 clinical trials, been successfully audited by the FDA and EMEA, and helped to bring over 250 drugs to markets. Through an uncompromising commitment to quality and service, a reputation for on-time performance, innovation at all levels, and delivery of services at reasonable costs, we have become trusted partners of many of the worlds leading pharmaceutical companies.